StockData
Evolus, Inc. logo

Evolus, Inc. (EOLS) stock

EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$7.00−0.07 (-0.99%)

Close on Nov 19, 2026Market cap $462.35MP/E –Yield –

Evolus revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Evolus's revenue for the twelve months ending Jun 30, 2026 was $316.49M, up 13.9% year over year. For fiscal 2025 it was $297.18M, up 11.6% from the year before. The highest annual figure on record is $297.18M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$297.18M+11.6%
FY2024Dec 31, 2024$266.27M+31.8%
FY2023Dec 31, 2023$202.09M+36.0%
FY2022Dec 31, 2022$148.62M+49.1%
FY2021Dec 31, 2021$99.67M+76.3%
FY2020Dec 31, 2020$56.54M+61.9%
FY2019Dec 31, 2019$34.93M–
FY2018Dec 31, 2018$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$84.08M+21.2%
Q1 FY2026Mar 31, 2026$73.14M+6.7%
Q4 FY2025Dec 31, 2025$90.30M+14.4%
Q3 FY2025Sep 30, 2025$68.97M+12.9%
Q2 FY2025Jun 30, 2025$69.39M+3.7%
Q1 FY2025Mar 31, 2025$68.52M+15.5%
Q4 FY2024Dec 31, 2024$78.95M+29.4%
Q3 FY2024Sep 30, 2024$61.09M+22.1%
Q2 FY2024Jun 30, 2024$66.91M+35.6%
Q1 FY2024Mar 31, 2024$59.33M+42.2%
Q4 FY2023Dec 31, 2023$61.00M+39.8%
Q3 FY2023Sep 30, 2023$50.02M+47.6%
Q2 FY2023Jun 30, 2023$49.35M+32.8%
Q1 FY2023Mar 31, 2023$41.72M+23.0%
Q4 FY2022Dec 31, 2022$43.65M+25.9%
Q3 FY2022Sep 30, 2022$33.90M+27.1%
Q2 FY2022Jun 30, 2022$37.16M+42.4%
Q1 FY2022Mar 31, 2022$33.91M+177.0%
Q4 FY2021Dec 31, 2021$34.66M+68.4%
Q3 FY2021Sep 30, 2021$26.68M+51.1%
Q2 FY2021Jun 30, 2021$26.10M+234.3%
Q1 FY2021Mar 31, 2021$12.24M+16.6%
Q4 FY2020Dec 31, 2020$20.58M+5.8%
Q3 FY2020Sep 30, 2020$17.66M+34.1%
Q2 FY2020Jun 30, 2020$7.81M+237.8%
Q1 FY2020Mar 31, 2020$10.50M–
Q4 FY2019Dec 31, 2019$19.45M–
Q3 FY2019Sep 30, 2019$13.17M–
Q2 FY2019Jun 30, 2019$2.31M–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–

More Evolus figures

See a number that looks wrong?